Delivery Order SPE2DB24D3013-SPE2DB24FFGEK
Award Date
7/12/24
Potential Completion Date
7/15/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of MENQUADFI VIAL 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of medical commodities,...
This federal contract award is for the delivery of MENQUADFI VIAL 0.5ML medical supplies, valued at $3,512.40, to the U.S. Department of Defense's (DoD) Medical Supply Chain. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a Firm Fixed Price basis. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 2025. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $47,337.10 with a firm fixed price, and the ultimate completion date is April 27, 2023. The contract is for the supply of MENQUADFI VIAL 0.5ML, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
This federal contract award, valued at $3,512.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The award is for the delivery of MENQUADFI VIAL 0.5ML, a pharmaceutical product, to support Department of Defense military treatment programs and facilities. The contract is a firm fixed price delivery order type, with a performance period ending on March 29, 2024....
This federal contract award is for the delivery of "MENQUADFI VIAL 0.5ML" medical supplies to the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, which is awarded a firm fixed-price delivery order contract with a ceiling value of $1,756.20. The contract is placed by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite...
This federal contract award, valued at $73,401.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of MENQUADFI VIAL 0.5ML, a medical product, with an ultimate completion date of November 3,...
This federal contract award is for the supply of MENQUADFI VIAL 0.5ML medical products to the Defense Logistics Agency (DLA), a defense agency. The $1,371.27 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 1, 2023 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order valued at $1,452.88 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENQUADFI VIAL 0.5ML, with a completion date of June 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a...
This federal contract award, with a ceiling value of $127,579.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,246,607 MENQUADFI VIAL 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 15, 2025. It is not designated as a set-aside contract, indicating open...
This federal contract award is for the delivery of MENQUADFI VIAL 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major supplier of pharmaceutical and medical products to the U.S. government. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $81,735.27. It does not have a set-aside designation. This award is associated with a larger...